NCT00287937View on ClinicalTrials.gov

Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

vorinostat

Given orally

DRUG

paclitaxel

Given IV

DRUG

carboplatin

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

15232

University of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00287937 - Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter